Introduction

Pain has been a major concern in the clinic for many decades. In recent years, considerable progress has been made with respect to our understanding of both acute and chronic pain mechanisms. This has largely been attributed to advancements in molecular biology and genomic techniques, as well as the use of animal models, which has allowed us to explore potential targets for pain. This has fundamentally altered our understanding of the pathophysiology of pain mechanisms and has led to the hope of development of novel analgesics.

The study of the receptor systems involved in the transmission of pain and its modulation involves investigation of processes occurring at the peripheral endings of sensory neurons, as well as central events. The mechanisms of inflammatory and neuropathic pain are different from those of acute pain, and there is considerable plasticity in both the transmission and modulating systems in these prolonged pain states. The search for new treatments for these pain states requires the development of valid animal models. For such models to be valid, a number of criteria must be fulfilled. First, the model must provide reproducible and quantifiable behavioral data. Second, the model must produce behaviors in the animal that resemble some of the pain syndromes observed in humans (e.g. allodynia, hyperalgesia). Third, the behavioral data must correlate with pain responses in humans. Through the use of these animal models, we can broaden our understanding of pain mechanisms and possibly identify or develop potential agents for treatment.